tiprankstipranks
Illumina (ILMN)
NASDAQ:ILMN
US Market
ILMN
Illumina
RESEARCH TOOLSreports
Want to see ILMN full AI Analyst Report?

Illumina (ILMN) Stock Forecast & Price Target

4,660 Followers
See the Price Targets and Ratings of:

ILMN Analyst Ratings

Moderate Buy
16Ratings
Moderate Buy
8 Buy
5 Hold
3 Sell
Based on 16 analysts giving stock ratings to
Illumina
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ILMN Stock 12 Month Forecast

Average Price Target

$192.44
▼(-0.85% Downside)
Based on 16 Wall Street analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $192.44 with a high forecast of $230.00 and a low forecast of $113.00. The average price target represents a -0.85% change from the last price of $194.09.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"93":"$93","162":"$162","231":"$231","127.5":"$127.5","196.5":"$196.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":230,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$230.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":192.4375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$192.44</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":113,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$113.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[93,127.5,162,196.5,231],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,205.1,207.01538461538462,208.93076923076922,210.84615384615384,212.76153846153846,214.67692307692306,216.59230769230768,218.5076923076923,220.42307692307693,222.33846153846153,224.25384615384615,226.16923076923078,228.08461538461538,{"y":230,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,205.1,204.12596153846152,203.15192307692308,202.1778846153846,201.20384615384614,200.2298076923077,199.25576923076923,198.28173076923076,197.3076923076923,196.33365384615385,195.35961538461538,194.3855769230769,193.41153846153847,{"y":192.4375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,205.1,198.01538461538462,190.93076923076922,183.84615384615384,176.76153846153846,169.67692307692306,162.59230769230768,155.5076923076923,148.4230769230769,141.33846153846153,134.25384615384615,127.16923076923077,120.08461538461538,{"y":113,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":94.66,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.82,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.26,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":123.54,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":128.72,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 10</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":131.16,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":141.13,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":132.89,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.63,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":135.78,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":164.4,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":183.89,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":205.1,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$230.00Average Price Target$192.44Lowest Price Target$113.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Freedom Capital Markets Analyst forecast on ILMN
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
$155→$185
Hold
-4.68%
Downside
Downgraded
08/05/26
Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker
Stifel Nicolaus Analyst forecast on ILMN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$225
Buy
15.93%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on ILMN
Casey Woodring
J.P. Morgan
J.P. Morgan
$230
Buy
18.50%
Upside
Reiterated
08/04/26
J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on ILMN
David Westenberg
Piper Sandler
Piper Sandler
$200→$225
Buy
15.93%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)
Canaccord Genuity Analyst forecast on ILMN
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$190→$205
Hold
5.62%
Upside
Reiterated
08/03/26
Canaccord Genuity Remains a Hold on Illumina (ILMN)
Citi Analyst forecast on ILMN
Patrick B Donnelly
Citi
Citi
$95→$113
Sell
-41.78%
Downside
Reiterated
08/03/26
Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi
TD Cowen Analyst forecast on ILMN
Daniel Brennan
TD Cowen
TD Cowen
$192→$210
Hold
8.20%
Upside
Assigned
07/31/26
TD Cowen Keeps Their Hold Rating on Illumina (ILMN)
Bernstein Analyst forecast on ILMN
Eve Burstein
Bernstein
Bernstein
$185→$215
Hold
10.77%
Upside
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Barclays Analyst forecast on ILMN
Luke Sergott
Barclays
Barclays
$145→$160
Sell
-17.56%
Downside
Reiterated
07/31/26
Barclays Sticks to Its Sell Rating for Illumina (ILMN)
Guggenheim Analyst forecast on ILMN
Subbu Nambi
Guggenheim
Guggenheim
$200→$226
Buy
16.44%
Upside
Reiterated
07/30/26
Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim
RBC Capital Analyst forecast on ILMN
Dan Leonard
RBC Capital
RBC Capital
$170→$230
Buy
18.50%
Upside
Assigned
07/30/26
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
Bank of America Securities Analyst forecast on ILMN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$100→$140
Sell
-27.87%
Downside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Illumina (NASDAQ: ILMN) and Siemens Healthineers AG (Other OTC: SEMHF)
Leerink Partners Analyst forecast on ILMN
Puneet Souda
Leerink Partners
Leerink Partners
$175→$210
Buy
8.20%
Upside
Reiterated
07/17/26
Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)
Evercore ISI Analyst forecast on ILMN
Vijay Kumar
Evercore ISI
Evercore ISI
$155→$200
Buy
3.04%
Upside
Reiterated
07/06/26
Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI
Jefferies Analyst forecast on ILMN
Tycho Peterson
Jefferies
Jefferies
$150
Hold
-22.72%
Downside
Reiterated
07/01/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Freedom Capital Markets Analyst forecast on ILMN
Ilya Zubkov
Freedom Capital Markets
Freedom Capital Markets
$155→$185
Hold
-4.68%
Downside
Downgraded
08/05/26
Illumina downgraded to Hold from Buy at Freedom BrokerIllumina downgraded to Hold from Buy at Freedom Broker
Stifel Nicolaus Analyst forecast on ILMN
Daniel Arias
Stifel Nicolaus
Stifel Nicolaus
$225
Buy
15.93%
Upside
Reiterated
08/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
J.P. Morgan Analyst forecast on ILMN
Casey Woodring
J.P. Morgan
J.P. Morgan
$230
Buy
18.50%
Upside
Reiterated
08/04/26
J.P. Morgan Keeps Their Buy Rating on Illumina (ILMN)
Piper Sandler Analyst forecast on ILMN
David Westenberg
Piper Sandler
Piper Sandler
$200→$225
Buy
15.93%
Upside
Reiterated
08/03/26
Analysts Offer Insights on Healthcare Companies: Illumina (NASDAQ: ILMN) and InspireMD (NASDAQ: NSPR)
Canaccord Genuity Analyst forecast on ILMN
Kyle Mikson CFA
Canaccord Genuity
Canaccord Genuity
$190→$205
Hold
5.62%
Upside
Reiterated
08/03/26
Canaccord Genuity Remains a Hold on Illumina (ILMN)
Citi Analyst forecast on ILMN
Patrick B Donnelly
Citi
Citi
$95→$113
Sell
-41.78%
Downside
Reiterated
08/03/26
Illumina price target raised to $113 from $95 at CitiIllumina price target raised to $113 from $95 at Citi
TD Cowen Analyst forecast on ILMN
Daniel Brennan
TD Cowen
TD Cowen
$192→$210
Hold
8.20%
Upside
Assigned
07/31/26
TD Cowen Keeps Their Hold Rating on Illumina (ILMN)
Bernstein Analyst forecast on ILMN
Eve Burstein
Bernstein
Bernstein
$185→$215
Hold
10.77%
Upside
Reiterated
07/31/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Illumina (NASDAQ: ILMN), Dyne Therapeutics (NASDAQ: DYN) and Bristol-Myers Squibb (NYSE: BMY)
Barclays Analyst forecast on ILMN
Luke Sergott
Barclays
Barclays
$145→$160
Sell
-17.56%
Downside
Reiterated
07/31/26
Barclays Sticks to Its Sell Rating for Illumina (ILMN)
Guggenheim Analyst forecast on ILMN
Subbu Nambi
Guggenheim
Guggenheim
$200→$226
Buy
16.44%
Upside
Reiterated
07/30/26
Illumina price target raised to $226 from $200 at GuggenheimIllumina price target raised to $226 from $200 at Guggenheim
RBC Capital Analyst forecast on ILMN
Dan Leonard
RBC Capital
RBC Capital
$170→$230
Buy
18.50%
Upside
Assigned
07/30/26
RBC Capital Keeps Their Buy Rating on Illumina (ILMN)
Bank of America Securities Analyst forecast on ILMN
Michael Ryskin
Bank of America Securities
Bank of America Securities
$100→$140
Sell
-27.87%
Downside
Reiterated
07/30/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alignment Healthcare (NASDAQ: ALHC), Illumina (NASDAQ: ILMN) and Siemens Healthineers AG (Other OTC: SEMHF)
Leerink Partners Analyst forecast on ILMN
Puneet Souda
Leerink Partners
Leerink Partners
$175→$210
Buy
8.20%
Upside
Reiterated
07/17/26
Analysts' Top Healthcare Picks: Insmed (INSM), Illumina (ILMN)
Evercore ISI Analyst forecast on ILMN
Vijay Kumar
Evercore ISI
Evercore ISI
$155→$200
Buy
3.04%
Upside
Reiterated
07/06/26
Illumina price target raised to $200 from $155 at Evercore ISIIllumina price target raised to $200 from $155 at Evercore ISI
Jefferies Analyst forecast on ILMN
Tycho Peterson
Jefferies
Jefferies
$150
Hold
-22.72%
Downside
Reiterated
07/01/26
Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), Illumina (NASDAQ: ILMN) and Protara Therapeutics (NASDAQ: TARA)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
ZURAZura Bio
TNYATenaya Therapeutics
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Illumina

3 Months
Patrick B DonnellyCiti
Success Rate
10/17 ratings generated profit
59%
Average Return
-0.34%
Copying Patrick B Donnelly's trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of -0.34% per trade.
1 Year
Vijay KumarEvercore ISI
Success Rate
11/18 ratings generated profit
61%
Average Return
+22.57%
Copying Vijay Kumar's trades and holding each position for 1 Year would result in 61.11% of your transactions generating a profit, with an average return of +22.57% per trade.
2 Years
Vijay KumarEvercore ISI
Success Rate
12/18 ratings generated profit
67%
Average Return
+31.64%
Copying Vijay Kumar's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +31.64% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ILMN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
6
6
9
16
14
Hold
11
6
4
9
9
Sell
5
6
6
7
4
Strong Sell
0
0
0
0
0
total
22
18
19
32
27
In the current month, ILMN has received 14 Buy Ratings, 9 Hold Ratings, and 4 Sell Ratings. ILMN average Analyst price target in the past 3 months is 192.44.
Each month's total comprises the sum of three months' worth of ratings.

ILMN Financial Forecast

ILMN Earnings Forecast

Next quarter’s earnings estimate for ILMN is $1.36 with a range of $1.33 to $1.38. The previous quarter’s EPS was $1.31. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 36.78% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ILMN is $1.36 with a range of $1.33 to $1.38. The previous quarter’s EPS was $1.31. ILMN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 36.78% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Sales Forecast

Next quarter’s sales forecast for ILMN is $1.15B with a range of $1.13B to $1.16B. The previous quarter’s sales results were $1.16B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.91% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.
Next quarter’s sales forecast for ILMN is $1.15B with a range of $1.13B to $1.16B. The previous quarter’s sales results were $1.16B. ILMN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.91% of the time in the same period. In the last calendar year ILMN has Performed in-line its overall industry.

ILMN Stock Forecast FAQ

What is ILMN’s average 12-month price target, according to analysts?
Based on analyst ratings, Illumina’s 12-month average price target is 192.44.
    What is ILMN’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for ILMN, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is ILMN a Buy, Sell or Hold?
        Illumina has a consensus rating of Moderate Buy which is based on 8 buy ratings, 5 hold ratings and 3 sell ratings.
          What is Illumina’s price target?
          The average price target for Illumina is 192.44. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $230.00 ,the lowest forecast is $113.00. The average price target represents -0.85% Decrease from the current price of $194.09.
            What do analysts say about Illumina?
            Illumina’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 16 Wall Streets Analysts.
              How can I buy shares of ILMN?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.